1-(3-{2-[3-(but-3-yn-1-yl)-3H-diazirin-3-yl]ethoxy}benzoyl)-6'-chloro-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one



Compound number:
MolPort-035-817-547
CAS number: 2034573-88-9
IUPAC:
1-(3-{2-[3-(but-3-yn-1-yl)-3H-diazirin-3-yl]ethoxy}benzoyl)-6'-chloro-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one
IUPAC traditional:
1-(3-{2-[3-(but-3-yn-1-yl)diazirin-3-yl]ethoxy}benzoyl)-6'-chloro-1',3'-dihydrospiro[piperidine-4,2'-quinazolin]-4'-one
SMILES:
Clc1ccc2NC3(CCN(CC3)C(=O)c3cccc(OCCC4(CCC#C)N=N4)c3)NC(=O)c2c1 |c:28|
InChI key:
WVRGYHITWYKOAH-UHFFFAOYSA-N
Molecular formula:
C26H26ClN5O3
Molecular weight: 491.98
Solubility: not available

Marketplace Offers

S&H to USA: 130.00 USD
S&H to World: 150.00 USD

Supplier Catalogue Data


Catalog: Screening compound Ships out: 6 business days Purity: >90%
Last updated: today In warehouse: 13.00 mg
Pack size Ships out Price Qty
2 micromol October 28, 2020 3135.00 USD
ADD TO CART
5 micromol October 28, 2020 3465.00 USD
ADD TO CART
10 micromol October 28, 2020 3795.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-035-817-547
CAS number: 2034573-88-9

Names, Synonyms and 3rd Party Identifiers
Name: ZINC000217426764
1-(3-(2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethoxy)benzoyl)-6'-chloro-1'H-spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

InChI
InChI: 1S/C26H26ClN5O3/c1-2-3-9-26(30-31-26)12-15-35-20-6-4-5-18(16-20)24(34)32-13-10-25(11-14-32)28-22-8-7-19(27)17-21(22)23(33)29-25/h1,4-8,16-17,28H,3,9-15H2,(H,29,33)
InChI key: WVRGYHITWYKOAH-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C26H26ClN5O3
Molecular weight: 491.98

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


2020 MolPort, v3.95, release date 18-10-2020 14:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.